1. Portnoy JM, Moffitt JE, Golden DB, et al; The Joint Force on Practice Parameters, the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. Stinging insect hypersensitivity: A practice parameter. J Allergy Clin Immunol 1999; 103: 963–980.
2. Golden DB, Kagey-Sobotka A, Lichtenstein LM. Survey of patients after discontinuing venom immunotherapy. J Allergy Clin Immunol 2000; 105: 385–390.
3. Hunt KJ, Valentine MD, Sobotka AK, et al. A controlled trial of immunotherapy in insect hypersensitivity. N Engl J Med 1978; 299: 157–161.
4. Reisman RE. Insect stings. N Engl J Med 1994; 331: 523–527.
5. Kemp SF, deShazo RD, Moffitt JE, et al. Expanding habitat of the imported fire ant (Solenopsis invicta): A public health concern. J Allergy Clin Immunol 2000; 105: 683–691.
6. Yates AB, Moffitt JE, deShazo RD: Anaphylaxis to arthropod bites and stings. Immunol Allergy Clin North Am 2001; 21: 635–651.
7. Yunginger JW: Insect allergy, in Middleton E, Reed CE, Ellis EF, et al (eds): Allergy: Principles and Practice. St. Louis, Mosby, 1998, vol 2, ed 5, pp 1063–1072.
8. Hoffman DR. Fire ant venom allergy. Allergy 1995; 50: 535–544.
9. Mauriello PM, Barde SH, Georgitis JW, et al. Natural history of large local reactions from stinging insects. J Allergy Clin Immunol 1984; 74: 494–498.
10. Golden DB, Kagey-Sobotka A, Norman PS, et al. Insect sting allergy with negative venom skin test responses. J Allergy Clin Immunol 2001; 107: 897–901.
11. Reisman RE. Insect sting allergy: The dilemma of the negative skin test reactor. J Allergy Clin Immunol 2001; 107: 781–782(editorial).
12. Hamilton RG, Golden DB, Kagey-Sobotka A, et al. Case report of venom immunotherapy for a patient with large local reactions. Ann Allergy Asthma Immunol 2001; 87: 134–137.
13. Valentine MD, Schuberth KC, Kagey-Sobotka A, et al. The value of immunotherapy with venom in children with allergy to insect stings. N Engl J Med 1990; 323: 1601–1603.
14. Golden DB. Stinging insect vaccines: Patient selection and administration of Hymenoptera venom immunotherapy. Immunol Allergy Clin North Am 2000; 20: 553–570.
15. Reisman RE, Livingston A. Venom immunotherapy: 10 years of experience with administration of single venoms and 50 μg maintenance doses. J Allergy Clin Immunol 1992; 89: 1189–1195.
16. Freeman TM, Hylander R, Ortiz A, et al. Imported fire ant immunotherapy: Effectiveness of whole body extracts. J Allergy Clin Immunol 1992; 90: 210–215.
17. Tankersley MS, Walker RL, Butler WK, et al. Safety and efficacy of an imported fire ant rush immunotherapy protocol with and without prophylactic treatment. J Allergy Clin Immunol 2002; 109: 556–562.
18. Stafford CT. Hypersensitivity to fire ant venom. Ann Allergy Asthma Immunol 1996; 77: 87–99.
19. Moffitt JE, Venarske D, Goddard J, et al. Allergic reactions to Triatoma bites. Ann Allergy Asthma Immunol 2003; 91: 122–130, 194.
20. McCormack DR, Salata KF, Hershey JN, et al. Mosquito bite anaphylaxis: Immunotherapy with whole body extracts. Ann Allergy Asthma Immunol 1995; 74: 39–44.
21. Hrabak TM, Dice JP. Use of immunotherapy in the management of presumed anaphylaxis to the deer fly. Ann Allergy Asthma Immunol 2003; 90: 351–354.